PRECIGEN, INC. Accounts and Other Receivables, Net, Current
PRECIGEN, INC. (PGEN) had Accounts and Other Receivables, Net, Current of $285.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsAndOtherReceivablesNetCurrent · last filed 2020-11-09
- 2020-09-30: Accounts and Other Receivables, Net, Current $285.00K.
- 2020-06-30: Accounts and Other Receivables, Net, Current $364.00K.
- 2020-03-31: Accounts and Other Receivables, Net, Current $351.00K.
- 2019-12-31: Accounts and Other Receivables, Net, Current $4.98M.
| Period end | Accounts and Other Receivables, Net, Current | Accounts and Other Receivables, Net, Current as first filed |
|---|---|---|
| 2020-09-30 | $285.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $364.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $351.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $4.98M 10-Q · filed 2020-11-09 | |
| 2019-09-30 | $1.97M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.87M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.58M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.26M 10-K · filed 2020-03-02 | $2.75M 10-K · filed 2019-03-01 |
| 2018-09-30 | $3.31M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.17M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $2.44M 10-Q/A · filed 2018-08-13 | |
| 2017-12-31 | $2.15M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $2.25M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.08M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.72M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $2.56M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $2.52M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $2.29M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $6.71M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $3.00M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $1.91M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $670.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $766.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $559.00K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $628.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $698.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $680.00K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $1.28M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $616.00K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $227.00K 10-Q/A · filed 2013-10-21 | |
| 2012-12-31 | $35.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |